Ibruxen 140 Mg (Ibrutinib) – 120 Capsules

Ibrutinib 140 mg is used for the treatment of severe types of cancer.  It helps to treat Mantle Cell Lymphoma (MCL) after at least one prior therapy. It is used for Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL). Patients who suffer from CLL or SLL with 17p deletion, Ibruxen 140 mg is an effective option for them.